-
Founded in:
1987-08-28 -
Country:
China -
Address:
Section B, Liutai Avenue, Chengdu Cross-Strait Science and Technology Industrial Development Park -
Tax NO.:
91510115201946724T -
Registered Funds:
70 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Naproxen |
This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins.
More
This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins. |
22204-53-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pantoprazole Sodium |
This product acts specifically on the gastric mucosal parietal cells, reducing the activity of H/KATPase in the parietal cells, thereby inhibiting the secretion of gastric acid. Compared with omeprazole and lansoprazole, this product has a weaker inhibitory effect on cytochrome P450-dependent enzymes. No adverse effects were found in either short-term or long-term administration of pantoprazole. This drug is non-carcinogenic, does not impair fertility, and does not induce teratogenesis. After 2.5 years of continuous medication, there were no changes in various experimental parameters of liver enzymology and cholesterol metabolism.
More
This product acts specifically on the gastric mucosal parietal cells, reducing the activity of H/KATPase in the parietal cells, thereby inhibiting the secretion of gastric acid. Compared with omeprazole and lansoprazole, this product has a weaker inhibitory effect on cytochrome P450-dependent enzymes. No adverse effects were found in either short-term or long-term administration of pantoprazole. This drug is non-carcinogenic, does not impair fertility, and does not induce teratogenesis. After 2.5 years of continuous medication, there were no changes in various experimental parameters of liver enzymology and cholesterol metabolism. |
138786-67-1 | 57 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pancreatin |
Contains pancreatic lipase, pancreatic amylase, and trypsin, which can respectively break down fat into glycerol and fatty acids, starch into sugar, and protein into peptone
More
Contains pancreatic lipase, pancreatic amylase, and trypsin, which can respectively break down fat into glycerol and fatty acids, starch into sugar, and protein into peptone |
300mg | 8049-47-6 | 27 |
| Pepsin |
Can convert protein into albumen and peptone
More
Can convert protein into albumen and peptone |
13mg | 9001-75-6 | 21 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ethambutol dihydrochloride |
This product is a synthetic antibacterial anti-tuberculosis drug. It has strong activity against bacteria in the growth and reproduction stage, and has almost no effect on bacteria in the dormant stage. It has high antibacterial activity against various types of mycobacteria. There is no cross-resistance between Mycobacterium tuberculosis and this product and other drugs. It may inhibit the metabolism of sensitive bacteria, inhibit RNA synthesis, and interfere with the protein metabolism of Mycobacterium tuberculosis, thereby causing bacterial death. In large doses, it can cause cleft palate, brain exposure, and spinal deformity in mouse experiments; it can cause mild cervical deformity in rat experiments; it can cause cyclops, short limbs, and cleft palate in rabbit experiments.
More
This product is a synthetic antibacterial anti-tuberculosis drug. It has strong activity against bacteria in the growth and reproduction stage, and has almost no effect on bacteria in the dormant stage. It has high antibacterial activity against various types of mycobacteria. There is no cross-resistance between Mycobacterium tuberculosis and this product and other drugs. It may inhibit the metabolism of sensitive bacteria, inhibit RNA synthesis, and interfere with the protein metabolism of Mycobacterium tuberculosis, thereby causing bacterial death. In large doses, it can cause cleft palate, brain exposure, and spinal deformity in mouse experiments; it can cause mild cervical deformity in rat experiments; it can cause cyclops, short limbs, and cleft palate in rabbit experiments. |
1070-11-7 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Piracetam |
It is a similar substance of aminobutyric acid, which can activate, protect and repair brain cells, improve brain hypoxia, activate brain cells, increase the ATP/ADP ratio in the brain, promote the absorption of amino acids and phospholipids, protein synthesis, glucose utilization and energy storage, promote brain metabolism, increase cerebral blood flow. It can accelerate the speed of information transmission between the cerebral hemispheres through the corpus callosum, and improve the ability of learning, memory and thinking activities.
More
It is a similar substance of aminobutyric acid, which can activate, protect and repair brain cells, improve brain hypoxia, activate brain cells, increase the ATP/ADP ratio in the brain, promote the absorption of amino acids and phospholipids, protein synthesis, glucose utilization and energy storage, promote brain metabolism, increase cerebral blood flow. It can accelerate the speed of information transmission between the cerebral hemispheres through the corpus callosum, and improve the ability of learning, memory and thinking activities. |
7491-74-9 | 24 |